These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Recombinant truncated flagellin of Burkholderia pseudomallei as a molecular probe for diagnosis of melioidosis. Chen YS; Shiuan D; Chen SC; Chye SM; Chen YL Clin Diagn Lab Immunol; 2003 May; 10(3):423-5. PubMed ID: 12738642 [TBL] [Abstract][Full Text] [Related]
23. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. Wiersinga WJ; Kager LM; Hovius JW; van der Windt GJ; de Vos AF; Meijers JC; Roelofs JJ; Dondorp A; Levi M; Day NP; Peacock SJ; van der Poll T J Immunol; 2010 Mar; 184(6):3079-86. PubMed ID: 20142364 [TBL] [Abstract][Full Text] [Related]
24. Flagellin-modulated inflammasome pathways characterize the human alveolar macrophage response to Lovelace-Macon L; Baker SM; Ducken D; Seal S; Rerolle G; Tomita D; Smith KD; Schwarz S; West TE Infect Immun; 2024 May; 92(5):e0006024. PubMed ID: 38619302 [TBL] [Abstract][Full Text] [Related]
25. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960 [TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of anti-flagellin antibody against Burkholderia pseudomallei in Taiwan. Chen YS; Chen SC; Wu TR; Kao CM; Chen YL Jpn J Infect Dis; 2004 Oct; 57(5):224-5. PubMed ID: 15507783 [No Abstract] [Full Text] [Related]
28. Melioidosis patient serum-reactive synthetic tetrasaccharides bearing the predominant epitopes of Burkholderia pseudomallei and Burkholderia mallei O-antigens. Cloutier M; Delar E; Muru K; Ndong S; Hoyeck RR; Kaewarpai T; Chantratita N; Burtnick MN; Brett PJ; Gauthier C Org Biomol Chem; 2019 Oct; 17(39):8878-8901. PubMed ID: 31513223 [TBL] [Abstract][Full Text] [Related]
29. Functional reconstitution, gene isolation and topology modelling of porins from Burkholderia pseudomallei and Burkholderia thailandensis. Siritapetawee J; Prinz H; Samosornsuk W; Ashley RH; Suginta W Biochem J; 2004 Feb; 377(Pt 3):579-87. PubMed ID: 14567756 [TBL] [Abstract][Full Text] [Related]
30. Flagellin gene variation between clinical and environmental isolates of Burkholderia pseudomallei contrasts with the invariance among clinical isolates. Winstanley C; Hales BA; Corkill JE; Gallagher MJ; Hart CA J Med Microbiol; 1998 Aug; 47(8):689-94. PubMed ID: 9877189 [TBL] [Abstract][Full Text] [Related]
31. Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach. Verma S; Sugadev R; Kumar A; Chandna S; Ganju L; Bansal A Vaccine; 2018 Jun; 36(28):4014-4022. PubMed ID: 29861180 [TBL] [Abstract][Full Text] [Related]
32. CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Chen YS; Hsiao YS; Lin HH; Liu Y; Chen YL Infect Immun; 2006 Mar; 74(3):1699-705. PubMed ID: 16495541 [TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Brett PJ; Mah DC; Woods DE Infect Immun; 1994 May; 62(5):1914-9. PubMed ID: 7513308 [TBL] [Abstract][Full Text] [Related]
34. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice. Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445 [TBL] [Abstract][Full Text] [Related]
36. Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063. Gourlay LJ; Peano C; Deantonio C; Perletti L; Pietrelli A; Villa R; Matterazzo E; Lassaux P; Santoro C; Puccio S; Sblattero D; Bolognesi M Acta Crystallogr D Biol Crystallogr; 2015 Nov; 71(Pt 11):2227-35. PubMed ID: 26527140 [TBL] [Abstract][Full Text] [Related]
37. Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis. Gilmore G; Barnes J; Ketheesan N; Norton R Clin Vaccine Immunol; 2007 Nov; 14(11):1529-31. PubMed ID: 17804613 [TBL] [Abstract][Full Text] [Related]
38. Involvement of B. pseudomallei RpoS in apoptotic cell death in mouse macrophages. Lengwehasatit I; Nuchtas A; Tungpradabkul S; Sirisinha S; Utaisincharoen P Microb Pathog; 2008 Mar; 44(3):238-45. PubMed ID: 18022342 [TBL] [Abstract][Full Text] [Related]
39. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB. McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370 [TBL] [Abstract][Full Text] [Related]
40. Biomarker discovery in the biofilm-forming process of Burkholderia pseudomallei by mass-spectrometry. Hadpanus P; Permsirivisarn P; Roytrakul S; Tungpradabkul S J Microbiol Methods; 2019 Apr; 159():26-33. PubMed ID: 30797019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]